158 related articles for article (PubMed ID: 25281429)
1. Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice.
Troy-Fioramonti S; Demizieux L; Gresti J; Muller T; Vergès B; Degrace P
Diabetes; 2015 Mar; 64(3):808-18. PubMed ID: 25281429
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats.
Sibaev A; Yuece B; Allescher HD; Saur D; Storr M; Kurjak M
Pharmacol Rep; 2014 Apr; 66(2):256-63. PubMed ID: 24911079
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system and the molecular basis of paralytic ileus in mice.
Mascolo N; Izzo AA; Ligresti A; Costagliola A; Pinto L; Cascio MG; Maffia P; Cecio A; Capasso F; Di Marzo V
FASEB J; 2002 Dec; 16(14):1973-5. PubMed ID: 12397089
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex.
Yuece B; Sibaev A; Broedl UC; Marsicano G; Göke B; Lutz B; Allescher HD; Storr M
Neurogastroenterol Motil; 2007 Sep; 19(9):744-53. PubMed ID: 17727394
[TBL] [Abstract][Full Text] [Related]
6. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
7. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
8. Effect of vanilloid drugs on gastrointestinal transit in mice.
Izzo AA; Capasso R; Pinto L; Di Carlo G; Mascolo N; Capasso F
Br J Pharmacol; 2001 Apr; 132(7):1411-6. PubMed ID: 11264233
[TBL] [Abstract][Full Text] [Related]
9. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M
Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in acute gastric damage and pancreatitis.
Dembiński A; Warzecha Z; Ceranowicz P; Dembiński M; Cieszkowski J; Pawlik WW; Konturek SJ; Tomaszewska R; Hładki W; Konturek PC
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():137-54. PubMed ID: 17218765
[TBL] [Abstract][Full Text] [Related]
12. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
14. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.
Di Marzo V; Capasso R; Matias I; Aviello G; Petrosino S; Borrelli F; Romano B; Orlando P; Capasso F; Izzo AA
Br J Pharmacol; 2008 Mar; 153(6):1272-80. PubMed ID: 18223666
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
17. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids and the gut.
Pinto L; Capasso R; Di Carlo G; Izzo AA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
[TBL] [Abstract][Full Text] [Related]
19. Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion.
Prestifilippo JP; Fernández-Solari J; Medina V; Rettori V; Elverdin JC
Alcohol Alcohol; 2009; 44(5):443-8. PubMed ID: 19589828
[TBL] [Abstract][Full Text] [Related]
20. ENP11, a potential CB1R antagonist, induces anorexia in rats.
Méndez-Díaz M; Amancio-Belmont O; Hernández-Vázquez E; Ruiz-Contreras AE; Hernández-Luis F; Prospéro-García O
Pharmacol Biochem Behav; 2015 Aug; 135():177-81. PubMed ID: 26072692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
